VillageMD CEO named Cornell Entrepreneur of the Year 2024

Tim Barry ’93 co-founded a health care company that offers primary care, multispecialty and urgent care options to 1.6 million patients throughout the U.S.

With ‘Cramp Bites,’ student creates remedy to relieve period pain

An undergrad’s Middle Eastern-flavored snacks that aim to minimize menstrual cramps – and that have been tested in a pilot study on campus – are now on sale through her company, Aunt Flo’s Kitchen.

Vaping labels challenge: Encouraging adults, dissuading kids

In a recent study published in Social Science and Medicine, a multidisciplinary team sought to deepen regulators’ understanding of how both adults and teens respond to warning labels on e-cigarettes.

SARS-CoV-2 can infect dopamine neurons, causing senescence

Further research may shed light on the neurological symptoms associated with long COVID, such as brain fog, lethargy and depression.

'Shredding' cancer cells: Study of CRISPR-Cas3 brings us closer

 Cornell researchers have taken an important step toward harnessing CRISPR gene editing in “targeted, safe and potent” cancer treatment.

Around Cornell

Stromal cells may help predict prostate cancer metastasis

Non-cancerous cells called stromal cells, which are found in and around prostate tumors, may be useful in assessing these tumors’ potential to spread, and may even be targets for future prostate cancer treatments, according to a study led by researchers at Weill Cornell Medicine.

Mouse model may help explain, treat infertility

Researchers in the Baker Institute for Animal Health have created a genetically engineered mouse model that could shed light on the causes of human infertility and allow researchers to explore other areas of reproduction.

Study teases out strategies to prevent fatal deer disease re-entering NY

Deer hunters were more likely to be swayed by social media messages about the potential risks of chronic wasting disease if they came from a source they believed aligned with their own views and values.

Adding radiation to lung cancer treatment improves outcomes

A new study found that patients with non-small cell lung cancer treated with a combination of low-dose radiation and immunotherapy had higher progression-free survival compared to patients who received immunotherapy alone.